VitaDAO funds early-stage aging research and DeSci projects, which aligns with the applicant's computational modeling and open-science approach. However, the applicant's focus is on addiction neuroscience and drug resistance, not directly aging, so fit is moderate. The applicant's independent researcher status and preprint-first approach may appeal to VitaDAO's decentralized ethos.